Evidence map›Paper›PMID 24068245›Full record

ArticleJAMA psychiatry2013

A nationwide study of the association between celiac disease and the risk of autistic spectrum disorders.

Jonas F Ludvigsson, Abraham Reichenberg, Christina M Hultman, Joseph A Murray

Open access · greenAbstract read
In one paragraph

Article in JAMA psychiatry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed, 2 pooled it
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 2 syntheses or guidelines pooled it, 88 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Assessing the causal association between celiac disease and autism spectrum disorder: A two-sample Mendelian randomization approach.Autism research : official journal of the International Society for Autism Research · 2025
    Article
  6. Article
  7. Observational
  8. Article
  9. Article
  10. Observational
  11. Article
  12. Article
  13. Article
  14. Article
  15. Immune Dysregulation in Autism Spectrum Disorder: What Do We Know about It?International journal of molecular sciences · 2022
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 3 countries.

Jonas F LudvigssonDepartment of Medicine, Clinical Epidemiology Unit, Karolinska University Hospital, Stockholm, Sweden2Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden3Department of Pediatrics, Orebro University Hospital, Orebro University, Orebro, Sweden4Division of Gastroenterology and Hepatology, Department of Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota.
Abraham Reichenberg
Christina M Hultman
Joseph A Murray
Karolinska Institutet · SEKarolinska University Hospital · SEKing's College London · GBMayo Clinic · US

Funding

EPIDEMIOLOGY OF CELIAC DISEASE--A POPULATION BASED STUDYR01DK057892 · NIDDK · MAYO CLINIC ROCHESTER · PI MURRAY, JOSEPH A · 2000 to 2010
$3.9M
A HLA Mouse Model for Gluten Sensitivity and EnteropathyR01DK071003 · NIDDK · MAYO CLINIC ROCHESTER · PI MURRAY, JOSEPH A · 2006 to 2009
$1.1M
A HLA Mouse Model for Gluten Sensitivity and EnteropathyR56DK071003 · NIDDK · MAYO CLINIC ROCHESTER · PI MURRAY, JOSEPH A · 2010 to 2010
$394k
NIDDK NIH HHS DK057892NIDDK NIH HHS DK071003NIDDK NIH HHS R01 DK057892NIDDK NIH HHS R01 DK071003NIDDK NIH HHS R56 DK071003
6 · The paper itself

Abstract

importanceMost case reports suggest an association between autistic spectrum disorders (ASDs) and celiac disease (CD) or positive CD serologic test results, but larger studies are contradictory.

objectiveTo examine the association between ASDs and CD according to small intestinal histopathologic findings. DESIGN AND

settingNationwide case-control study in Sweden. MAIN OUTCOMES AND MEASURES: Through 28 Swedish biopsy registers, we collected data about 26,995 individuals with CD (equal to villous atrophy, Marsh stage 3), 12,304 individuals with inflammation (Marsh stages 1-2), and 3719 individuals with normal mucosa (Marsh stage 0) but positive CD serologic test results (IgA/IgG gliadin, endomysium, or tissue transglutaminase) and compared them with 213,208 age- and sex-matched controls. Conditional logistic regression estimated odds ratios (ORs) for having a prior diagnosis of an ASD according to the Swedish National Patient Register. In another analysis, we used the Cox proportional hazards regression model to estimate hazard ratios (HRs) for future ASDs in individuals undergoing small intestinal biopsy.

resultsA prior ASD was not associated with CD (OR, 0.93; 95% CI, 0.51-1.68) or inflammation (OR 1.03; 95% CI, 0.40-2.64) but was associated with a markedly increased risk of having a normal mucosa but a positive CD serologic test result (OR, 4.57; 95% CI, 1.58-13.22). Restricting our data to individuals without a diagnosis of an ASD at the time of biopsy, CD (HR, 1.39; 95% CI, 1.13-1.71) and inflammation (HR, 2.01; 95% CI, 1.29-3.13) were both associated with moderate excess risks of later ASDs, whereas the HR for later ASDs in individuals with normal mucosa but positive CD serologic test results was 3.09 (95% CI, 1.99-4.80). CONCLUSIONS AND RELEVANCE: Although this study found no association between CD or inflammation and earlier ASDs, there was a markedly increased risk of ASDs in individuals with normal mucosa but a positive CD serologic test result.

Indexed as

AtrophyAutistic DisorderCase-Control StudiesCeliac DiseaseFemaleHumansInflammationIntestinal MucosaIntestine, SmallMaleRegistriesRisk FactorsSerologic TestsSweden

Identifiers

PMID24068245
PMCPMC3884520
OpenAlexW1994600271

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.